Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

New Androgen Receptor Axis-Targeted Agents inthe Treatment of Nonmetastatic Castration-ResistantProstate Cancer: From Bench to Clinical Trials

Hong JH

Bone metastasis is a common sign of disease progression in nonmetastatic castration-resistant prostate cancer(nmCRPC). It has been known to be associated with significant morbidity and mortality. Delaying or preventingdevelopment of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epigenetic Approaches to the Treatment of Renal Cell Cancer

Hong SH, Lee J, Jang EB, Park SY, Moon HS, Yoon YE

To summarize the epigenetics in renal cell carcinoma (RCC) and discuss the potential use of epigenetic modifiersas RCC biomarkers and treatments. Pertinent articles available on PubMed and google scholar database...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Approaches for Personalized Drug Development in Bladder Cancer Patients

Seol HS, Chang IH

Bladder cancer, which affects the bladder mucosa, is the ninth most common disease worldwide. There are manytypes of cancerous tissue in the bladder. Most exhibit low malignancy, but their recurrence...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Open Partial Nephrectomy With Zero IschemiaTechnique Using Thulium Laser: Our Experience of4 Cases

Prem K, Kumar P, Rehman ZU, Janoria S

With the advent of newer technologies, the management of small renal masses has shown a paradigm shift.This has resulted in preferring partial nephrectomy over radical nephrectomy, emphasizing the concept of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Estramustine Phosphate Monotherapy in Castration-Resistant Prostate Cancer Patients Who Cannot Receive Cytotoxic Chemotherapy

Ryu JH, Kim SJ, Kim YB, Jung TY, Moon KT, Cho JM, Yoo TK

Purpose: To investigate whether estramustine phosphate (EMP) monotherapy is applicable to castration-resistantprostate cancer (CRPC) patients who cannot receive cytotoxic chemotherapy. Materials and Methods: This retrospective single-arm study was conducted in CRPC...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Potential Utility of Prostate Health Index Density for Prostate Cancer Detection and Prediction in Korean Men: A Prospective Multicenter Study

Song G, Park H, Lee SW, Kang TW, Jung JH, Chung HC, Kim SJ, Park JY, Kim JH

Purpose: We evaluated the clinical performance of Prostate Health Index (PHI) density with [-2]proPSA (p2PSA)and its derivatives in predicting the presence of prostate cancer (PCa) in Korean men. Materials and Methods:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum Testosterone Level Can Be Predictive Factor for Upstaging in Clinically Localized Prostate Cancer

Kwon SO, Byeon KH, Chung JW, Ha YS, Choi SH, Kim BS, Kim HT, Kim TH, Yoo ES, Yoon GS, Lee JN, Kwon TG

Purpose: To determine an appropriate surgical technique, it is important to predict pathological results for patientswith clinically localized prostate cancer (PCa) eligible for nerve-sparing radical prostatectomy (NSRP). Severalstudies have highlighted...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk Factors for pT3a Prostate Cancerin the Patients With cT1-2 on PreoperativeMultiparametric Magnetic Resonance Imaging

Kim KH, Ku JY, Park WY, Hong SB, Kim S, Ha HK

Purpose: Our study aimed to evaluate the predictive value of multiparametric magnetic resonance imaging (mpMRI)to assess the capsular extension of prostate cancer. Risk factors for extraprostatic invasion or microscopic invasionof...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic Options in High-Risk Nonmuscle Invasive Bladder Cancer During the Shortage of Bacillus Calmette-Guérin

Yoo J, Kim YJ, Tae BS, Park JY

Bladder cancer is the second most common malignant tumor of the urinary tract and is the seventh most commoncancer among men worldwide and 17th among women. Seventy to eighty percent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of Patients With Advanced Prostate Cancer: Establishment ofTreatment Guidelines Through Prostate Cancer Summit (PCAS) 2016Composed of Korean Prostate Cancer Experts

Jang CT, Kim HJ, Kim MK, Park SW, Park SC, Park JY, Lee DH, Lee SH, Jeon HG, Chung JH, Jeong H, Jo MK, Hong SH, Kwak C, Lee JY, Kwon DD, Kim CS, Jeon SS

Purpose: The Advanced Prostate Cancer Consensus Conference (APCCC) 2015 was based on topics withcontroversy in the field of advanced prostate cancer. To understand the Korean urologists perspective regardingthe issues, we...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr